Director, Search & Evaluation Early Ta Lead Immunology

CSL Behring

Melbourne, Australia
Base: $232,000 - $284,000 usd; bonus/equity: incen...
12+ years biopharma experience
External innovation search & evaluation
Early-stage deal closing track record
The role involves leading proactive sourcing efforts to build a robust pipeline of preclinical and Phase 1 assets aligned with therapeutic area strategy

Job Summary

  • The role involves leading proactive sourcing efforts to build a robust pipeline of preclinical and Phase 1 assets aligned with therapeutic area strategy.
  • Candidates will co-lead internal meetings to evaluate New Product Opportunities and drive cross-functional due diligence for governance decisions.
  • CSL Behring is a global biotherapeutics leader employing 32,000 people who deliver lifesaving therapies to over 100 countries.

Matching Summary

The role involves leading proactive sourcing efforts to build a robust pipeline of preclinical and Phase 1 assets aligned with therapeutic area strategy.

Salary

Base: $232,000 - $284,000 USD; Bonus/Equity: Incentive compensation and equity included; Benefits: Not specified

Skills & Requirements

Must-have

  • 12+ years biopharma experience
  • External innovation search & evaluation
  • Early-stage deal closing track record
  • Deep scientific expertise in Immunology
  • Cross-functional due diligence leadership

Nice-to-have

  • Strong network in biotech communities
  • Experience with academic partnerships
  • Agile team collaboration skills
  • Strategic positioning for priority assets

Key Requirements

  • Advanced degree (PhD, MD, or equivalent)
  • 12+ years in biopharma industry
  • Proven track record of closing early-stage deals
  • Expertise in Hematology or Cardiovascular/Renal areas

Work Rights

Not specified

Tailored Resume

Cover Letter